Pancreatic P-cell mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) plays a major role in glucoseinduced insulin secretion. Decreased activity of this enzyme has thus been proposed to play a role in the pathogenesis of NIDDM. Cloning of human insulinoma mGPDH cDNAs disclosed the existence of two variant transcripts with different 5' ends. Reverse transcription polymerase chain reaction (PCR) confirmed the presence of both mGPDH mRNAs in purified native human pancreatic islets and other tissues. A major 6.5-Kb mGPDH transcript was detected by Northern blot analysis in RNA from human and rat pancreatic islets, with distinctly lower levels in other human tissues, indicating that previously reported high mGPDH enzymatic activity in P-cells is determined by high transcript levels. The mGPDH gene was mapped to chromosome 2 by PCR analysis of genomic DNA from human/rodent somatic cell hybrids, and five independent overlapping yeast artificial chromosome (YAC) clones containing the mG-PDH sequence were identified from the Centre d'Etude du Polymorphisme Humain YAC library. Analysis of these YAC clones identified a highly polymorphic chromosome 2q21-q33 dinucleotide repeat genetic marker (D2S141) physically linked to the mGPDH gene. These studies provide the means to investigate the role of the human mGPDH gene in the pathogenesis of NIDDM and illustrate the value of a novel strategy to identify genetic markers for diabetes candidate genes. Diabetes 45:262-266, 1996
cytosis (1) . NADH-reducing equivalents generated from the oxidation of glyceraldehyde-3-phosphate are a major substrate for glycolvtically derived ATP production in mitochondrial oxidative phosphorylation (3, 4) . The transfer into the mitochondria of electrons from cytosolic NADH is largely mediated by the glycerol phosphate shuttle (5) . Flavinadenine dinucleotide-linked mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) is a key enzyme in this shuttle system (5) , and its catalytic activity is 40-to 70-fold higher in pancreatic islets and insulinoma relative to other tissues, such as whole pancreas, liver, or skeletal muscle. Thus, preferential mitochondrial oxidation of utilized glucose is greatly favored in these cells (6) . It has been postulated that decreased (3-cell mGPDH activity could result in diminished glycolvtically derived ATP production and hence in impaired glucose-stimulated insulin secretion (7, 8) . There is now evidence for the existence of abnormal pancreatic islet mGPDH activity in several animal models of diabetes, as well as in a limited number of humans with NIDDM (7) (8) (9) . Thus, variations in the sequence or level of expression of the human mGPDH gene may contribute to the pathogenesis of NIDDM.
The cDNAs encoding rat testes, liver and islets, as well as human cervical carcinoma cell mGPDH have been recently isolated (10) (11) (12) (13) . We have cloned mGPDH cDNAs from a human pancreatic (3-cell tumor and examined mGPDH mRNA in native human islets by reverse transcription (RT) polymerase chain reaction (PCR). The results indicate the existence of a novel alternate 5' untranslated sequence, while a predicted translated sequence nearly identical to that present in other rat and human tissues was observed. We show for the first time that, in accordance with previous studies demonstrating high mGPDH activity in p-cells, the abundance of pancreatic islet mGPDH mRNA is distinctly higher than that observed in other tissues (6) . The gene encoding mGPDH was mapped to yeast artificial chromosome (YAC) clones that form part of a defined contig on the long arm of chromosome 2, and a flanking polymorphic dinucleotide marker for NIDDM linkage studies was thus identified.
RESEARCH DESIGN AND METHODS
Screening of a human (J-cell tumor cDNA library and sequence analysis. A partial 749 bp human mGPDH cDNA fragment was isolated with PCR from human islet reverse transcribed cDNA, using degenerate primers 5'-AGC(A/G/T)GG(A/T)GG(G/A/C/T)AA(A/G)TGGACCAC(A/G/ C/T)TA-3' and 5'-AG(C/T)TC(A/C/T)ACCTG(A/G/C/T)CCATT(C/T)TT(A/ G)TT-3' derived from the published sequence of rat testes mGPDH (Genbank/EMBL accession no. U08027). This partial cDNA fragment was 32 P-labeled by random priming to a specific activity greater than 1 X 10 9 cpm/(xg and used as a hybridization probe to screen 5 X 10 5 pfu from a human insulinoma cDNA library cloned in \ ZAP II, essentially as described (14) . Sequencing was carried out on an ABI 373A automated sequencer, and the resulting sequences were compared with the nonredundant nucleic acid and protein databases (National Center for Biotechnology Information) using BLASTN and BLASTX algorithms. Tissue procurement and RNA isolation. Tissue preparations that were enriched by density gradient centrifugation for either human pancreatic islets or pancreatic exocrine tissue were obtained from the Human Islet Transplantation Center, Washington University Medical School (WUMS) (Dr. David Scharp). Other human tissues were obtained through a rapid autopsy protocol (Drs. J. Saffitz and R. Schmidt, Department of Pathology, WUMS), or from a surgical specimen (Dr. J. Norton, Department of Surgery, WUMS). All human tissue was obtained with institutional approval and informed consent. Rat pancreatic islets were obtained by a modified collagenase procedure, as previously described (15) . (3TC6-F7 cells were a gift from Dr. Shimon Efrat (Albert Einstein College of Medicine, Bronx, NY). Total RNA was extracted by homogenization in guanidinium thiocyanate and cesium chloride gradient ultracentrifugation or by a modified two-step procedure using Trizol (BRL, Bethesda, MD) reagent as recommended by the manufacturer. Northern blot and RT-PCR analysis. Northern blots prepared with total RNA samples and a Multiple Tissue Northern (Clontech, Palto Alto, CA) polyA + RNA blot were hybridized with an a-32 P-labeled cDNA probe corresponding to the 3' 2.2 Kb Ncol digestion product of INSmGPDH cDNA insert or with a (3-actin cDNA probe and washed at a final stringency of 0.1 x sodium chloride-sodium citrate, 0.1% SDS at 65°C before exposure to X-ray film for 48 h.
RT-PCR was carried out with human pancreatic islet, insulinoma, muscle, cerebellum, and liver total RNAs treated with RNAse-free DNAse (GIBCO-BRL), extracted with phenol-chloroform, ethanol precipitated, and quantified by spectrophotometry. The integrity and accuracy of quantitation of RNA was then ascertained by ethidium bromideformaldehyde gel electrophoresis. cDNA was synthesized from 1 |xg total RNA by oligo-dT priming with Superscript II reverse transcriptase (GIBCO-BRL). PCR amplification was carried out from cDNA corresponding to 80 ng total RNA for 30 cycles at 94°C, 52-60°C, and 72°C for 1 min each step, with a final extension at 72°C for 10 min. Primers used for RT-PCR were 5'-AGACTTGCACTGAAGGTGCA-3' (M0), 5'-AGGAGAAGC-
. PCR products were resolved on an ethidium bromidestained 2% agarose gel and visualized under ultraviolet light. Chromosomal localization by somatic cell hybrid and mega-YAC library analysis. The chromosomal assignment of mGPDH was determined by PCR amplification of DNA from a panel of rodent/human somatic cell hybrids (NIGMS Mutant Cell Repository, Camden, NJ). A sequence-tagged site (STS) derived from the 3' coding and untranslated region of Ins-mGPDH cDNA was developed for this purpose, using primers M9 and M10. PCR amplification was carried out for 30 cycles at 95°, 56°, and 72°C for 1 min each step, with a final extension at 72°C for 10 min. Reaction products were analyzed on an ethidium bromidestained 2% agarose gel.
Physical mapping to YACs was carried out by PCR screening of the large-insert Centre d'Etude du Polymorphisme Humain (CEPH) "B" YAC library, purchased from Research Genetics (Huntsville, AL) (16) . An aliquot (1 |xl) of each 24-"block" YAC DNA pool (representing 18,432 clones) was amplified in a 10-|xl reaction, using the same STS and cycling parameters described for somatic cell hybrid analysis. was obtained using the Whitehead Institute/MIT Center for Genome Research World-Wide Web servers, and further analysis of markers contained by these clones was done using the Genome Data Base and Cooperative Human Linkage Center servers.
RESULTS
Isolation of a human insulinoma mGPDH cDNA. Screening of 5 X 10 5 clones from a human insulinoma cDNA library with a partial mGPDH probe generated by PCR led to the isolation of 12 3,085-bp cDNA clones (INS-mGPDH). Sequence analysis revealed an open frame encoding a 727-amino acid protein, 96% identical to that reported from rat liver and testes (11, 12) . During the course of this work, a Hela epithelial cell line mGPDH cDNA (Genbank accession no. U12424) was reported that contained an open-reading frame that differed in a single amino acid (R525H), resulting from a G to A substitution at nucleotide position 2095 of INS-mGPDH. This amino acid change did not affect any of the three conserved functional domains of mGPDH that were initially predicted from the rat sequence, namely the calcium-, flavin adenine dinucleotide-, and glycerol phosphatebinding sites (12) . Also, compared with the Hela cell mGPDH cDNA, INS-mGPDH had a silent base change in position 1910, three single nucleotide substitutions in the 3' untranslated region (positions 2773, 2836, and 2867), an additional 69 bp in the 3' end that contained a polyadenylation signal (not shown), and completely diverged in the 509-bp 5' segment located 12 bp upstream from the predicted initiator methionine (5' UTR "A", Fig. 1) (10) . This insulinoma mGPDH 5' untranslated region had no significant homology with any of the two previously identified rat liver and testes 5' untranslated region variants, whereas 60% homology exists between the human Hela and rat liver cDNA 5' untranslated regions (10) (11) (12) . INS-mGPDH contained an in-frame ochre stop codon at position -6 from the initiator AUG, thus discarding possible alternate mGPDH translation products derived from this clone. Assessment of mGPDH mRNA sequence heterogeneity by RT-PCR. The alternate 5'-untranslated regions identified in INS-mGPDH (Fig. 1, 5 ' UTR A) and Hela mGPDH (5' UTR B) cDNAs were further investigated by RT-PCR of native human islet and insulinoma RNA. Forward oligonucleotide primers (Ml, Ml') corresponding to regions located 50 or 108 bp upstream from the translation initiation codon of INSmGPDH (5' UTR A) and Hela mGPDH cDNAs (5' UTR B), respectively, and a reverse primer complementary to the first-strand cDNA of multiple human tissues, using primers Ml, Ml', and M2 (see Fig. 1 for approximate location), and analyzed by 2% agarose gel electrophoresis. 5' UTR A-speciflc product is 99 bp; 5' UTR B-speciflc product is 157 bp.
common 5' coding region (M2) revealed the two expected amplification products in human islet, insulinoma, liver, cerebellum, and skeletal muscle cDNA. This was tested with the two primer pair combinations separately (not shown) or combined to simultaneously assess the presence of the two sequences in different tissues (Fig. 2) . While RT-PCR experiments proved that the 100-bp sequence 5' of the putative translation start codon of INSmGPDH (5' UTR A) forms part of islet-cell mGPDH mRNAs, the 383-bp segment situated in the 5'-most end of this untranslated region (schematized as a thin line in Fig. 1 ) likely represents an artifactual concatemer. BLASTN sequence database analysis shows that this segment contains a sequence that is 94-97% identical to the putative 3' end of anonymous-expressed sequence tags isolated from different directionally cloned human cDNA libraries (Genbank accession nos. D20040, D29540). RT-PCR using a forward primer corresponding to this region (MO) and a reverse primer complementary to a region in the 5' end of the mGPDH coding sequence (M2) failed to amplify the intervening sequence predicted from the INS-mGPDH cDNA using human pancreatic islet, insulinoma, or liver cDNA, while the expected size fragment was readily amplified from a diluted aliquot of the cDNA library (not shown).
RT-PCR analysis was also used to confirm that the coding sequence of mGPDH present in the insulinoma cDNA is also expressed in native human pancreatic islets. Five primer sets were designed to amplify different segments spanning the entire coding region (Ml + M2, Ml + M4, M3 + M6, M5 + M7, and M8 -I-Mil, schematized in Fig. 1 ) and used for RT-PCR amplification of human islet RNA. The amplification products were sized by agarose gel electrophoresis and directly sequenced, resulting in products identical to those expected from the insulinoma cDNA (not shown). These findings are thus consistent with the existence of a human islet-cell mGPDH protein with a primary structure that is analogous to that reported in other tissues (10) (11) (12) (13) (14) . Tissue distribution of mGPDH. Northern blot analysis was carried out with a 32 P-labeled 2.2-Kb cDNA fragment corresponding to the 3' portion of INS-mGPDH. A distinct 6.5-Kb transcript was detected in 8 |xg total RNA from human islets after 5 days' exposure, while RNAs of identical size, but at least 10-fold lower in intensity, were detected in other human tissues such as brain, muscle, and heart (Fig. 3A) . Very faint 4.4-Kb and diffuse 2.4-to 3.1-Kb bands were also seen in most tissues. A similarly distinct 6.5-Kb band was observed in 2 fxg total RNA prepared from rat pancreatic islets and more intensely in (3TC6-F7 tumor (3-cell line RNA (Fig. 3B) . Hybridization of an mGPDH probe generated by RT-PCR with a multiple-tissue Northern blot prepared with 2 j uug poly A + RNA also disclosed the presence of a major 6.5-Kb band in all tissues, while minor bands of 12 Kb, 3.1 Kb, and 2.8 Kb could also be readily observed after prolonged exposures (Fig. 3C) . The abundance of mGPDH transcripts among this panel of human tissues, which did not include human islet RNA, was highest in skeletal muscle, where an intense 4.4-Kb transcript was observed in addition to those described above. Chromosomal localization of mGPDH. The gene encoding mGPDH was localized to chromosome 2 by segregation analysis of a panel of human-rodent somatic-cell hybrids containing different human chromosomes, using an STS defined by primers M8 and M9 corresponding to the 3' coding and untranslated regions of INS-mGPDH cDNA (not shown). With the same PCR assay, 7 positives were identified from 24 block pools from the CEPH "B" YAC library. Five of these were arbitrarily chosen for further analysis, and this led to the identification of five unique mega-YAC genomic clones (Fig. 4) 
DISCUSSION
Because the selective loss of glucose-stimulated insulin secretion is a well-characterized defect in humans with NIDDM, the key molecules involved in (3-cell glucose sensing are logical candidates for use in investigating the pathophysiology of this disorder (1) . mGPDH is believed to be a major component in the p-cell glucose recognition apparatus, since it contributes to preferential oxidative metabolism of glucose and consequently to the generation of signals that result in insulin secretion (4) . The results of the current study indicate that in spite of the specific role that mGPDH plays in P-cell physiology, human islet-cell RNAs encode a nearly identical protein to that previously characterized in a Hela cell line (10) . Interestingly, a novel alternate 5' untranslated region was identified in both native and tumor human islet cells. The existence of different 5' untranslated mGPDH mRNA regions is of potential interest because this finding suggests the presence of alternate promoters and/or the existence of variable translational efficiency in different cell types or developmental stages. This could in turn provide an explanation for the existence of tissue-specific differences in the regulated or constitutive levels of expression of this gene. Interestingly, thyroid hormone is known to enhance the activity of this enzyme in liver, where basal activity is low, but not in islet cells and testes, where mGPDH activity is normally elevated (13) . Although the RT-PCR coamplification experiments shown here have not detected the use of a single variant in any of the tested tissues, purified human islets and other tissues we have analyzed have a heterogeneous cellular composition. Given that mGPDH mRNA appears to be expressed ubiquitously, our PCR studies have not discarded the possibility that a single alternate 5'-untranslated sequence is expressed in certain cell types, including native human p-cells. A striking finding from the studies shown here is the presence of a distinctly increased abundance of mGPDH mRNA in pancreatic islets. While no data had been previously reported regarding the relative abundance of mGPDH mRNA in rat or human tissues, pancreatic islet and tumor (3-cell mGPDH catalytic activity is known to markedly exceed that of a variety of other tissues, including muscle, liver, heart, and pancreas. This is in keeping with the alleged critical role of this enzyme in the p-cell glucose-sensing apparatus (3, 6) . Therefore, the present Northern blot results show that these tissue differences in mGPDH activity are dependent on the existence of high mRNA levels in pancreatic islet cells. Previous studies described the presence of a 2.4-Kb mRNA in testes but failed to detect this mRNA in other tissues (11) . Although we did not assess RNA from human testes, we consistently detected a major 6.5-Kb transcript in a panel of human tissues and detected only a less-abundant 2.4-Kb form, using either a partial INS-mGPDH cDNA fragment or an RT-PCR fragment-generated mGPDH probe under high-stringency hybridization conditions. It is possible that the 2.4-Kb testes transcript observed by others reflects a tissue-specific variation, while differences in RNA blotting-assay sensitivity may account for the lack of hybridization signal in the remaining tissues that has been previously reported (11) . Given the well-documented existence of decreased mGPDH activity in multiple animal models of diabetes (7, 8) our finding that mGPDH transcripts can be readily detected in relatively small amounts of human islet total RNA will be useful for studies aimed at the assessment of the expression of this gene in islets from individuals with NIDDM.
We have now placed the mGPDH gene in a well-characterized region of the human genome physical map by screening the CEPH "B" genome-wide YAC library, coupled with confirmation by somatic cell hybrid chromosomal assignment. To this point, no form of NIDDM or other inherited disorder has to our knowledge been mapped to this precise chromosomal region. While an insulin-dependent diabetes susceptibility locus (IDDM 7) has been linked to a nearby genetic marker, recent analysis with multiple regional markers has refined this locus to a slightly more telomeric region near D2S152 (17) . An important feature of the current study is that we have successfully used a novel resource to reliably locate a highly polymorphic microsatellite in the vicinity of the mGPDH gene. This marker can now be used in linkage studies to assess the role of the mGPDH gene in the inherited susceptibility to NIDDM.
